Cadila Healthcare’s arm inks pact with Integrace

21 Sep 2021 Evaluate

Cadila Healthcare’s wholly-owned subsidiary -- Zydus Healthcare has entered into an agreement on September 20, 2021 with Integrace (Purchaser) to sell two brands viz. Mifegest and Cytolog. The said transaction is expected to be completed within 30 days from the date of execution of agreement, subject to customary approvals. Purchaser is a part of the portfolio companies of PE firm True North.

Cadila Healthcare is an India-based pharmaceutical company. The company's subsidiaries include Zydus Wellness, Liva Pharmaceuticals, Biochem Pharmaceutical Industries, Zydus Technologies, German Remedies, Dialforhealth India, Dialforhealth Unity and Dialforhealth Greencross, among others.

Zydus Lifesciences Share Price

958.90 -0.55 (-0.06%)
23-Apr-2024 15:41 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1483.75
Dr. Reddys Lab 5947.30
Cipla 1347.70
Zydus Lifesciences 958.90
Lupin 1580.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.